A U.S. health advisory committee has released updated guidance on polio vaccination for adults. The recommendations focus on the use of the inactivated polio vaccine, which is the only type available in the United States. The report is an official update from the Advisory Committee on Immunization Practices (ACIP), which helps set the country's vaccination schedules.
The guidance is specifically for adults living in the United States. The report itself does not contain details from a new study, such as how many people were involved or what specific outcomes were measured. It also does not report on any new safety concerns or side effects related to the vaccine.
It is important to understand that this is an update to official recommendations, not a report on new scientific research. The committee reviewed existing evidence to decide when adults should get this vaccine. Readers should see this as updated guidance from health officials on who should consider the polio vaccine and when, rather than as news about a newly discovered benefit or risk.